AQR Capital Management
CNMD icon

AQR Capital Management’s CONMED CNMD Stock Holding History

AQR Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84M Buy
80,229
+34,489
+75% +$1.4M ﹤0.01% 2123
2025
Q4 		$1.86M Buy
45,740
+29,841
+188% +$1.3M ﹤0.01% 2164
2025
Q3 		$748K Buy
15,899
+2,157
+16% +$112K ﹤0.01% 2597
2025
Q2 		$716K Sell
13,742
-457
-3% -$25.1K ﹤0.01% 2410
2025
Q1 		$857K Buy
14,199
+2,357
+20% +$152K ﹤0.01% 2127
2024
Q4 		$810K Sell
11,842
-34,519
-74% -$2.41M ﹤0.01% 2003
2024
Q3 		$3.33M Sell
46,361
-1,325
-3% -$93.5K ﹤0.01% 1245
2024
Q2 		$3.31M Buy
47,686
+27,897
+141% +$2.03M 0.01% 1231
2024
Q1 		$1.58M Buy
+19,789
New +$1.76M ﹤0.01% 1504
2022
Q3 		– Sell
-3,708
Closed -$355K – 2214
2022
Q2 		$355K Buy
3,708
+472
+15% +$56.6K ﹤0.01% 1801
2022
Q1 		$481K Buy
3,236
+24
+0.7% +$3.35K ﹤0.01% 1835
2021
Q4 		$455K Sell
3,212
-5
-0.2% -$708 ﹤0.01% 1855
2021
Q3 		$421K Buy
3,217
+648
+25% +$84.8K ﹤0.01% 1926
2021
Q2 		$353K Sell
2,569
-362
-12% -$49.6K ﹤0.01% 2003
2021
Q1 		$383K Sell
2,931
-4,692
-62% -$565K ﹤0.01% 1929
2020
Q4 		$854K Sell
7,623
-789
-9% -$74.7K ﹤0.01% 1569
2020
Q3 		$662K Buy
+8,412
New +$686K ﹤0.01% 1615
2020
Q2 		– Sell
-9,282
Closed -$532K – 2111
2020
Q1 		$532K Sell
9,282
-5,156
-36% -$475K ﹤0.01% 1564
2019
Q4 		$1.61M Sell
14,438
-3,690
-20% -$393K ﹤0.01% 1348
2019
Q3 		$1.74M Sell
18,128
-2,795
-13% -$262K ﹤0.01% 1323
2019
Q2 		$1.79M Sell
20,923
-1,641
-7% -$135K ﹤0.01% 1302
2019
Q1 		$1.88M Buy
22,564
+1,689
+8% +$123K ﹤0.01% 1340
2018
Q4 		$1.34M Sell
20,875
-23,826
-53% -$1.63M ﹤0.01% 1403
2018
Q3 		$3.54M Buy
44,701
+21,093
+89% +$1.63M ﹤0.01% 1146
2018
Q2 		$1.73M Buy
23,608
+12,867
+120% +$875K ﹤0.01% 1493
2018
Q1 		$681K Buy
+10,741
New +$641K ﹤0.01% 1810
2017
Q1 		– Sell
-12,901
Closed -$570K – 2192
2016
Q4 		$570K Sell
12,901
-5,968
-32% -$254K ﹤0.01% 1883
2016
Q3 		$756K Sell
18,869
-23,698
-56% -$1.01M ﹤0.01% 1814
2016
Q2 		$2.03M Sell
42,567
-2,393
-5% -$101K ﹤0.01% 1288
2016
Q1 		$1.89M Sell
44,960
-5,109
-10% -$201K ﹤0.01% 1271
2015
Q4 		$2.21M Sell
50,069
-19,178
-28% -$832K ﹤0.01% 1193
2015
Q3 		$3.31M Sell
69,247
-79,129
-53% -$4.34M 0.01% 929
2015
Q2 		$8.65M Sell
148,376
-51,892
-26% -$2.8M 0.02% 656
2015
Q1 		$10.1M Sell
200,268
-54,100
-21% -$2.65M 0.02% 539
2014
Q4 		$11.4M Sell
254,368
-8,961
-3% -$376K 0.02% 622
2014
Q3 		$9.7M Buy
263,329
+7,100
+3% +$282K 0.03% 605
2014
Q2 		$11.3M Sell
256,229
-3,700
-1% -$168K 0.03% 589
2014
Q1 		$11.3M Sell
259,929
-3,600
-1% -$160K 0.03% 549
2013
Q4 		$11.2M Sell
263,529
-38,177
-13% -$1.45M 0.03% 557
2013
Q3 		$10.3M Sell
301,706
-127,901
-30% -$4.17M 0.04% 556
2013
Q2 		$13.4M Buy
+429,607
New +$13.9M 0.05% 468

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AQR Capital Management's CNMD Position: Q1 2026 in Review

AQR Capital Management increased its CONMED (CNMD) stake by 75% in Q1 2026, buying an estimated $1.4M and bringing the position to 80,229 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

AQR Capital Management first reported a position in CNMD in Q2 2013 and has held it in 41 quarters since. The position peaked at $13.4M in Q2 2013. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • AQR Capital Management held 80,229 shares of CONMED worth $2.84M as of Q1 2026.
  • AQR Capital Management bought 34,489 CONMED shares in Q1 2026, an estimated $1.4M.
  • CONMED made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2123 holding.
  • AQR Capital Management first reported a position in CONMED in Q2 2013 and has held it in 41 quarters since.
  • AQR Capital Management's CONMED position peaked at $13.4M in Q2 2013.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.